KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-cash Items (2020 - 2023)

Ginkgo Bioworks Holdings' Non-cash Items history spans 4 years, with the latest figure at $14.6 million for Q2 2023.

  • For Q2 2023, Non-cash Items fell 66.58% year-over-year to $14.6 million; the TTM value through Jun 2023 reached $14.6 million, down 66.58%, while the annual FY2022 figure was $15.9 million, 91.43% down from the prior year.
  • Non-cash Items reached $14.6 million in Q2 2023 per DNA's latest filing, up from $11.0 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $386.0 million in Q4 2020 to a low of $11.0 million in Q1 2023.
  • Average Non-cash Items over 4 years is $86.3 million, with a median of $29.1 million recorded in 2021.
  • The largest YoY upside for Non-cash Items was 43.82% in 2022 against a maximum downside of 91.43% in 2022.
  • A 4-year view of Non-cash Items shows it stood at $386.0 million in 2020, then tumbled by 51.91% to $185.6 million in 2021, then crashed by 91.43% to $15.9 million in 2022, then dropped by 8.1% to $14.6 million in 2023.
  • Per Business Quant, the three most recent readings for DNA's Non-cash Items are $14.6 million (Q2 2023), $11.0 million (Q1 2023), and $15.9 million (Q4 2022).